Literature DB >> 11115053

The HCV National Register: towards informing the natural history of hepatitis C infection in the UK.

H E Harris1, M E Ramsay, J Heptonstall, K Soldan, K P Eldridge.   

Abstract

The aim of this paper is to describe the development of a national hepatitis C register and the completeness of the data it contains. This is a descriptive report of the structure and function of the register, including case definitions, registration and follow-up procedures, and methods used to maximize data quality and to obtain comparative data sources. The register contains data on HCV-infected individuals who acquired their infections on a known date and by a known route; to date all are transfusion recipients identified during the UK lookback exercise, who tested positive or indeterminate for anti-HCV after receiving 'infected' blood issued before the introduction of routine testing of the blood supply for anti-HCV. By 31 December 1999, 871 (87%) of 996 eligible transfusion recipients had been registered, and 984 (99%) flagged in the NHS Central Registers. Registered patients had been infected for an average of 11.1 years (SEM 0.1); around half were being cared for by clinicians with a specialist interest in liver disease. Except for the information on tobacco use, current alcohol use, and hepatitis B status, data were more than 80% complete, and for most variables, more than 90% complete. The consistency of data abstraction was found to be 98% (SEM 0.5). In conclusion, the Register contains high quality anonymised data on one of the largest cohorts of individuals with HCV infections acquired on a known date and by a known route. It could serve as a model for other chronic disease registers; developers may find the structure, design, and methodological issues addressed useful.

Entities:  

Mesh:

Year:  2000        PMID: 11115053     DOI: 10.1046/j.1365-2893.2000.00255.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

1.  Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure.

Authors:  H E Harris; M E Ramsay; N J Andrews
Journal:  Epidemiol Infect       Date:  2005-10-28       Impact factor: 2.451

Review 2.  Perinatal hepatitis C virus infection: diagnosis and management.

Authors:  S M Davison; G Mieli-Vergani; J Sira; D A Kelly
Journal:  Arch Dis Child       Date:  2006-09       Impact factor: 3.791

3.  Clinical course of hepatitis C virus during the first decade of infection: cohort study.

Authors:  Helen E Harris; Mary E Ramsay; Nick Andrews; Keith P Eldridge
Journal:  BMJ       Date:  2002-02-23

Review 4.  Alcoholic liver disease and hepatitis C: a frequently underestimated combination.

Authors:  Sebastian Mueller; Gunda Millonig; Helmut K Seitz
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

5.  The impact of mode of acquisition on biological markers of paediatric hepatitis C virus infection.

Authors:  K England; C Thorne; H Harris; M Ramsay; M-L Newell
Journal:  J Viral Hepat       Date:  2011-06-22       Impact factor: 3.728

6.  Improved hepatitis C treatment response in younger patients: findings from the UK HCV National Register cohort study.

Authors:  H E Harris; A Costella; G Amirthalingam; G Alexander; M E B Ramsay; N Andrews
Journal:  Epidemiol Infect       Date:  2011-11-29       Impact factor: 2.451

7.  Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug-drug interactions and hepatitis C cure.

Authors:  Salamat Ali; Tofeeq Ur-Rehman; Eleri Lougher; David Mutimer; Mashhood Ali; Vibhu Paudyal
Journal:  Int J Clin Pharm       Date:  2020-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.